IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q3 2022 Holdings

Filed 2022-11-14 | 3 holdings | $48.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$48.5M3,846,15499.7%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$168.0K1,111,1110.3%
Viracta Therapeutics IncCOM92765F108$163,7000.0%